Botson et al. 152 patient RCT. MTX combo with pegloticase (to decrease antidrug abs). 6-month response (sUA<6 mg/dL) 71% vs 39%. Infusion reactions 3% vs 31%. @RheumNow #EULAR2022 OP0171 https://t.co/N29kYT3xkR https://t.co/Z4dUMD4Tt3
Links:
EULAR Abstract Archive
http://scientific.sparx-ip.net/archiveeular/?c=a&searchfor=OP0171&view=1&item=2…
01-06-2022